| Title |
Carnitine supplementation for inborn errors of metabolism
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2012
|
| DOI | 10.1002/14651858.cd006659.pub3 |
| Pubmed ID | |
| Authors |
Mona Nasser, Hoda Javaheri, Zbys Fedorowicz, Zaman Noorani |
| Abstract |
Inborn errors of metabolism are genetic conditions which can lead to abnormalities in the synthesis and metabolism of proteins, carbohydrates, or fats. It has been proposed that in some instances carnitine supplementation should be provided to infants with a suspected metabolic disease as an interim measure, particularly whilst awaiting test results. Carnitine supplementation is used in the treatment of primary carnitine deficiency, and also where the deficiency is a secondary complication of several inborn errors of metabolism, such as organic acidaemias and fatty acid oxidation defects in children and adults. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Australia | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 183 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 15% |
| Student > Bachelor | 24 | 13% |
| Researcher | 20 | 11% |
| Student > Ph. D. Student | 17 | 9% |
| Student > Doctoral Student | 11 | 6% |
| Other | 40 | 21% |
| Unknown | 47 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 55 | 29% |
| Nursing and Health Professions | 22 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Agricultural and Biological Sciences | 8 | 4% |
| Biochemistry, Genetics and Molecular Biology | 8 | 4% |
| Other | 29 | 16% |
| Unknown | 56 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2014.
All research outputs
#16,783,081
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,370
of 11,842 outputs
Outputs of similar age
#171,870
of 258,519 outputs
Outputs of similar age from Cochrane database of systematic reviews
#162
of 216 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,519 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.